Related Experiment Video
Updated: Oct 30, 2025

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
Low-Dose Antibiotic Prophylaxis Induces Rapid Modifications of the Gut Microbiota in Infants With Vesicoureteral
William Morello1, Federica D'Amico2, Jessica Serafinelli1
1Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Insights
Continuous low-dose antibiotic prophylaxis (CAP) in infants with VUR alters the gut microbiota, increasing opportunistic pathogens. This early antibiotic exposure may pose long-term health risks.
Area of Science:
- Microbiology
- Pediatrics
- Gastroenterology
Background:
- Infant gut microbiota (GM) development is crucial and influenced by environmental factors.
- Continuous low-dose antibiotic prophylaxis (CAP) is standard for VUR to prevent urinary tract infections.
- Understanding CAP's short-term impact on infant GM is essential.
Purpose of the Study:
- To evaluate the short-term effects of CAP on the gut microbiota composition in infants with VUR.
- To compare GM structure between infants exposed and not exposed to CAP.
Main Methods:
- Analysis of gut microbiota in 87 infants (1-5 months) with VUR using 16S rRNA gene sequencing.
- Comparison of GM profiles between infants on CAP and those not exposed.
- Assessment of fecal short- and branched-chain fatty acids.
Main Results:
- CAP-exposed infants showed altered GM composition, with increased Enterobacteriaceae and Bacteroidetes (e.g., Bacteroides, Parabacteroides).
- A trend towards increased Klebsiella, associated with antibiotic resistance, was observed in CAP-exposed infants.
- Non-CAP infants had a GM enriched in Bifidobacterium.
Conclusions:
- Even short-term CAP significantly alters infant gut microbiota in VUR patients.
- CAP exposure increases opportunistic pathogens and decreases beneficial bacteria.
- Early low-dose antibiotic use may carry potential long-term clinical risks.
Abstract:
Background and Objectives: Maturation of the gut microbiota (GM) in infants is critically affected by environmental factors, with potential long-lasting clinical consequences. Continuous low-dose antibiotic prophylaxis (CAP) is the standard of care for children with vesicoureteral reflux (VUR), in order to prevent recurrent urinary tract infections. We aimed to assess short-term GM modifications induced by CAP in infants. Methods: We analyzed the GM structure in 87 infants (aged 1-5 months) with high-grade VUR, previously exposed or naïve to CAP. Microbial DNA was extracted from stool samples. GM profiling was achieved by 16S rRNA gene-based next-generation sequencing. Fecal levels of short- and branched-chain fatty acids were also assessed. Results: 36/87 patients had been taking daily CAP for a median time of 47 days, while 51/87 had not. In all patients, the GM was predominantly composed by Bifidobacteriaceae and Enterobacteriaceae. Subgroup comparative analysis revealed alterations in the GM composition of CAP-exposed infants at phylum, family and genus level. CAP-exposed GM was enriched in members of Enterobacteriaceae and Bacteroidetes, especially in the genera Bacteroides and Parabacteroides, and showed a trend toward increased Klebsiella, often associated with antibiotic resistance. In contrast, the GM of non-CAP children was mostly enriched in Bifidobacterium. No differences were found in fatty acid levels. Conclusions: In infants with VUR, even a short exposure to CAP definitely alters the GM composition, with increased relative abundance of opportunistic pathogens and decreased proportions of health-promoting taxa. Early low-dose antibiotic exposure might bear potential long-term clinical risks.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs for Treatment of Constipation-Predominant IBS
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

